Sarepta Therapeutics, Inc. — Director's Dealing 2021

Feb 13, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2020-12-31

Reporting Person: Barry Richard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-10	Common Stock	G	6500	$0.00	Disposed	3122640	Direct

Footnotes

F1: Represents a charitable donation to an educational institution.